Process characterisation of a manufactured living dermal equivalent (ICX-SKN) and use of ultrasound for product improvement
The routine use of regenerative medicine products in patients requires cost-effective manufacturing processes and products that meet business and customer needs. The dermal skin substitute lCX-SKN, produced by lntercytex for the treatment of acute wounds, completed Phase I clinical trials in 2007. l...
Saved in:
| Main Author: | |
|---|---|
| Format: | Default Thesis |
| Published: |
2009
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/12537 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|